Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Zivanovic

Showing results (61-70 of 204) with videos related to

Pageof 21
Sort By:
Obstetrics and Gynecology|May 24, 2012
Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancerStephan Polterauer, Susan Khalil, Oliver Zivanovic, et al.
Cancer|April 23, 2008
Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-upOliver Zivanovic, Richard R Barakat, Paul J Sabbatini, et al.
Onkologie|June 19, 2013
Interval debulking surgery in patients with Federation of Gynecology and Obstetrics (FIGO) stage IIIC and IV ovarian cancerMignon-Denise Keyver-Paik, Oliver Zivanovic, Christian Rudlowski, et al.
Gynecologic Oncology|October 4, 2016
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer centerJennifer J Mueller, Amelia Kelly, Qin Zhou, et al.
Gynecologic Oncology|December 4, 2020
Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse eventsAlli M Straubhar, Jennifer L Wolf, Ms Qin C Zhou, et al.
Breast Cancer Research and Treatment|October 2, 2007
Influence of preoperative MRI on the surgical management of patients with operable breast cancerMichael Braun, Martin Pölcher, Simone Schrading, et al.
Gynecologic Oncology|October 11, 2011
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancerEdward J Tanner, Destin R Black, Oliver Zivanovic, et al.
Cancer|March 5, 2013
External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcomaAlexia Iasonos, Emily Z Keung, Oliver Zivanovic, et al.
Gynecologic Oncology|September 22, 2009
Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed?Fady Khoury-Collado, Gretchen E Glaser, Oliver Zivanovic, et al.
Gynecologic Oncology|September 11, 2017
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancerRenee A Cowan, Jill Tseng, Vijayashree Murthy, et al.
Pageof 21

Showing results (61-70 of 204) with videos related to

Sort By:
Pageof 21
Obstetrics and Gynecology|May 24, 2012
Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancerStephan Polterauer, Susan Khalil, Oliver Zivanovic, et al.
Cancer|April 23, 2008
Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-upOliver Zivanovic, Richard R Barakat, Paul J Sabbatini, et al.
Onkologie|June 19, 2013
Interval debulking surgery in patients with Federation of Gynecology and Obstetrics (FIGO) stage IIIC and IV ovarian cancerMignon-Denise Keyver-Paik, Oliver Zivanovic, Christian Rudlowski, et al.
Gynecologic Oncology|October 4, 2016
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer centerJennifer J Mueller, Amelia Kelly, Qin Zhou, et al.
Gynecologic Oncology|December 4, 2020
Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse eventsAlli M Straubhar, Jennifer L Wolf, Ms Qin C Zhou, et al.
Breast Cancer Research and Treatment|October 2, 2007
Influence of preoperative MRI on the surgical management of patients with operable breast cancerMichael Braun, Martin Pölcher, Simone Schrading, et al.
Gynecologic Oncology|October 11, 2011
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancerEdward J Tanner, Destin R Black, Oliver Zivanovic, et al.
Cancer|March 5, 2013
External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcomaAlexia Iasonos, Emily Z Keung, Oliver Zivanovic, et al.
Gynecologic Oncology|September 22, 2009
Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed?Fady Khoury-Collado, Gretchen E Glaser, Oliver Zivanovic, et al.
Gynecologic Oncology|September 11, 2017
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancerRenee A Cowan, Jill Tseng, Vijayashree Murthy, et al.
Pageof 21